Pacific Biosciences of California (PACB)
(Delayed Data from NSDQ)
$1.56 USD
+0.12 (8.33%)
Updated Aug 23, 2024 03:59 PM ET
After-Market: $1.55 -0.01 (-0.64%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth B Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/4/24 |
---|---|
Current Quarter | -0.20 |
EPS Last Quarter | -0.20 |
Last EPS Surprise | 16.67% |
ABR | 2.00 |
Earnings ESP
|
11.11% |
---|---|
Current Year | -0.96 |
Next Year | -0.69 |
EPS (TTM) | -1.00 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 41.90M | 52.04M | 168.07M | 214.70M |
# of Estimates | 5 | 4 | 5 | 5 |
High Estimate | 45.00M | 55.71M | 170.51M | 227.04M |
Low Estimate | 39.45M | 49.00M | 164.20M | 199.00M |
Year ago Sales | 55.69M | 58.36M | 200.52M | 168.07M |
Year over Year Growth Est. | -24.77% | -10.83% | -16.18% | 27.74% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.20 | -0.21 | -0.96 | -0.69 |
# of Estimates | 4 | 4 | 4 | 5 |
Most Recent Consensus | NA | NA | -1.27 | NA |
High Estimate | -0.16 | -0.14 | -0.83 | -0.48 |
Low Estimate | -0.27 | -0.27 | -1.27 | -0.91 |
Year ago EPS | -0.27 | -0.27 | -1.11 | -0.96 |
Year over Year Growth Est. | 25.93% | 22.22% | 13.51% | 27.86% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 2 | 1 | 2 | 3 |
Up Last 60 Days | 2 | 1 | 2 | 3 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 2 | 1 | 0 |
Down Last 60 Days | 1 | 2 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.20 | -0.21 | -0.96 | -0.69 |
7 Days Ago | -0.20 | -0.21 | -0.96 | -0.69 |
30 Days Ago | -0.21 | -0.21 | -0.87 | -0.75 |
60 Days Ago | -0.21 | -0.21 | -0.87 | -0.75 |
90 Days Ago | -0.22 | -0.21 | -0.87 | -0.75 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.18 | -0.19 | -0.99 | -0.61 |
Zacks Consensus Estimate | -0.20 | -0.21 | -0.96 | -0.69 |
Earnings ESP | 11.11% | 10.04% | -3.39% | 11.59% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.20 | -0.26 | -0.27 | -0.27 | NA |
Estimate | -0.24 | -0.26 | -0.31 | -0.30 | NA |
Difference | 0.04 | 0.00 | 0.04 | 0.03 | 0.03 |
Surprise | 16.67% | 0.00% | 12.90% | 10.00% | 9.89% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more